BrainStorm Cell Therapeutics
BCLI
#10182
Rank
C$9.76 M
Marketcap
$1.59
Share price
-3.45%
Change (1 day)
-89.33%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.80

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.84. In 2022 the company made an earnings per share (EPS) of -$0.94 an increase over its 2021 EPS that were of -$0.96.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.80-14.82%
2022-$0.94-2.94%
2021-$0.96-37.04%
2020-$1.531.89%
2019-$1.5051.43%
2018-$0.99159.26%
2017-$0.38-3.57%
2016-$0.40-37.78%
2015-$0.64-33.82%
2014-$0.9636%
2013-$0.7111.11%
2012-$0.6450%
2011-$0.43-50%
2010-$0.85-233.33%
2009$0.64-142.86%
2008-$1.49-65%
2007-$4.26
2005$1.40-108.03%
2004-$17.5013203.07%
2003-$0.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$6.23-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.07 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.69 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.20-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.21 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA